These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7895324)

  • 1. Receptor-selective mutants of tumour necrosis factor in the therapy of cancer: preclinical studies.
    Brouckaert P; Ameloot P; Cauwels A; Everaerdt B; Libert C; Takahashi N; Van Molle W; Fiers W
    Circ Shock; 1994 Aug; 43(4):185-90. PubMed ID: 7895324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
    Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
    J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of and sensitization to the lethal effects of tumor necrosis factor.
    Brouckaert P; Libert C; Cauwels A; Everaerdt B; Van Molle W; Ameloot P; Gansemans Y; Grijalba B; Takahashi N; Truong MJ; Van Leuven P; Fiers W
    J Inflamm; 1995-1996; 47(1-2):18-26. PubMed ID: 8913926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration.
    Sato T; Yamauchi N; Sasaki H; Takahashi M; Okamoto T; Sakamaki S; Watanabe N; Niitsu Y
    Cancer Res; 1998 Apr; 58(8):1677-83. PubMed ID: 9563482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
    Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W; Vandenabeele P; Fiers W
    Cytokine; 1995 Oct; 7(7):701-9. PubMed ID: 8580379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
    Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
    Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TNF].
    Yamauchi N; Niitsu Y
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1486-94. PubMed ID: 9309146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P
    Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.
    Declercq W; Denecker G; Fiers W; Vandenabeele P
    J Immunol; 1998 Jul; 161(1):390-9. PubMed ID: 9647248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the 75-kDa TNF receptor in TNF-induced activation of neutrophil respiratory burst.
    Dri P; Haas E; Cramer R; Menegazzi R; Gasparini C; Martinelli R; Scheurich P; Patriarca P
    J Immunol; 1999 Jan; 162(1):460-6. PubMed ID: 9886420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha.
    Alaaeddine N; DiBattista JA; Pelletier JP; Cloutier JM; Kiansa K; Dupuis M; Martel-Pelletier J
    J Rheumatol; 1997 Oct; 24(10):1985-94. PubMed ID: 9330943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
    Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
    J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
    Remacle-Bonnet MM; Garrouste FL; Heller S; André F; Marvaldi JL; Pommier GJ
    Cancer Res; 2000 Apr; 60(7):2007-17. PubMed ID: 10766192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.